Brief: Lexeo Therapeutics Announces Closing Of Oversubscribed $95.0 Million Equity Financing
13/03/2024 20:49
Lexeo Therapeutics Inc LXEO.O :
* LEXEO THERAPEUTICS ANNOUNCES CLOSING OF OVERSUBSCRIBED
$95.0
MILLION EQUITY FINANCING
Source text for Eikon: ID:nGNX8Bl70j
Further company coverage: LXEO.O
Recent news on Lexeo Therapeutics
See all newsBrief: Lexeo Therapeutics Enters Into Agreement To Acquire Mantle Therapeutics And Announces Multiple New Strategic Collaborations To Expand Leadership In Friedreich Ataxia
Brief: Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
U.S. STOCKS ON THE MOVE-Datadog, Terawulf
Lexeo rises as co sets late-stage trial plan for gene therapy in rare heart disease